UM

Browse/Search Results:  1-10 of 101 Help

Selected(0)Clear Items/Page:    Sort:
Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson's disease Journal article
Hua, Lin, Huang, Canpeng, Zeng, Xinglin, Gao, Fei, Yuan, Zhen. Individualized brain radiomics-based network tracks distinct subtypes and abnormal patterns in prodromal Parkinson's disease[J]. NeuroImage, 2025, 306, 121012.
Authors:  Hua, Lin;  Huang, Canpeng;  Zeng, Xinglin;  Gao, Fei;  Yuan, Zhen
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.7/6.1 | Submit date:2025/01/22
Brain Radiomics-based Network  Clinical Symptoms  Disease Subtypes  Gene Expression  Prodromal Parkinson's Disease  
Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment Journal article
Cheng, Guowang, Liu, Zhiwen, Yan, Zhao, Wu, Jiaxin, Li, Zilin, Gao, Sijia, Zheng, Chunye, Guo, Shuanshuan, Pan, Yue, Chen, Xiaojia, Lin, Guanghui, Zhou, Jianhua, Chen, Tongkai. Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment[J]. Journal of Controlled Release, 2025, 377, 591-605.
Authors:  Cheng, Guowang;  Liu, Zhiwen;  Yan, Zhao;  Wu, Jiaxin;  Li, Zilin; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.5/10.6 | Submit date:2025/01/22
Parkinson's Disease  Cognitive Impairment  Blood-brain Barrier  Nanomedicine  Neuroprotection  
Novel C. elegans models of Lewy body disease reveal pathological protein interactions and widespread miRNA dysregulation Journal article
Li, Rongzhen, Huang, Xiaobing, Shen, Linjing, Zhang, Tianjiao, Liu, Ning, Hou, Xiangqing, Wong, Garry. Novel C. elegans models of Lewy body disease reveal pathological protein interactions and widespread miRNA dysregulation[J]. Cellular and Molecular Life Sciences, 2024, 81(1), 377.
Authors:  Li, Rongzhen;  Huang, Xiaobing;  Shen, Linjing;  Zhang, Tianjiao;  Liu, Ning; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:6.2/7.7 | Submit date:2024/10/10
Amyloid β  Parkinson’s Disease  Tar-dna-binding Protein 43  Tau Protein  Α-synuclein  
Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo Journal article
Shao, Min, Zhao, Chen, Pan, Zhijian, Yang, Xuanjun, Gao, Cheng, Kam, Gloria Hio Cheng, Zhou, Hefeng, Lee, Simon Ming Yuen. Oxyphylla A exerts antiparkinsonian effects by ameliorating 6-OHDA-induced mitochondrial dysfunction and dyskinesia in vitro and in vivo[J]. Chemico-Biological Interactions, 2024, 403, 111224.
Authors:  Shao, Min;  Zhao, Chen;  Pan, Zhijian;  Yang, Xuanjun;  Gao, Cheng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.7/4.6 | Submit date:2024/10/10
Parkinson's Disease  Oxyphylla a  6-ohda  Mitochondria  Neuroprotection  Target Prediction  
Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models Journal article
Guo, Baojian, Zheng, Chengyou, Cao, Jie, Luo, Fangcheng, Li, Haitao, Hu, Shengquan, Mingyuan Lee, Simon, Yang, Xifei, Zhang, Gaoxiao, Zhang, Zaijun, Sun, Yewei, Wang, Yuqiang. Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson's disease models[J]. Journal of Advanced Research, 2024, 64, 195-211.
Authors:  Guo, Baojian;  Zheng, Chengyou;  Cao, Jie;  Luo, Fangcheng;  Li, Haitao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:11.4/11.0 | Submit date:2024/02/22
Nuclear Factor Erythroid-2-related Factor 2  Parkinson's Disease  Peroxisome Proliferator-activated Receptor γ Co-activator 1α  Tetramethylpyrazine Nitrone  
Deep-Learning-Based Cross-Modality Striatum Segmentation for Dopamine Transporter SPECT in Parkinson’s Disease Journal article
Haiyan Wang, Han Jiang, Gefei Chen, Yu Du, Zhonglin Lu, Zhanli Hu,, MOK SENG PENG. Deep-Learning-Based Cross-Modality Striatum Segmentation for Dopamine Transporter SPECT in Parkinson’s Disease[J]. IEEE Transactions on Radiation and Plasma Medical Sciences, 2024, 8(7), 752-761.
Authors:  Haiyan Wang;  Han Jiang;  Gefei Chen;  Yu Du;  Zhonglin Lu; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.6/3.6 | Submit date:2024/08/08
Cross-modality  Deep Learning (Dl)  Parkinson’s Disease (Pd)  Spect  Striatum Segmentation  
Rasagiline Exerts Neuroprotection towards Oxygen–Glucose-Deprivation/Reoxygenation-Induced GAPDH-Mediated Cell Death by Activating Akt/Nrf2 Signaling Journal article
Lecht, Shimon, Lahiani, Adi, Klazas, Michal, Naamneh, Majdi Saleem, Rubin, Limor, Dong, Jiayi, Zheng, Wenhua, Lazarovici, Philip. Rasagiline Exerts Neuroprotection towards Oxygen–Glucose-Deprivation/Reoxygenation-Induced GAPDH-Mediated Cell Death by Activating Akt/Nrf2 Signaling[J]. Biomedicines, 2024, 12(7), 1592.
Authors:  Lecht, Shimon;  Lahiani, Adi;  Klazas, Michal;  Naamneh, Majdi Saleem;  Rubin, Limor; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.9/4.1 | Submit date:2024/08/05
Akt  Cell Death  Gapdh  Ischemia-like Insult  Neuroprotection  Nrf2  Phosphorylation  Rasagiline  Ros  Pc 12 Neuronal Model  Α-synuclein  Parkinson’s Disease  Stroke  
Radiomics incorporating deep features for predicting Parkinson’s disease in 123I-Ioflupane SPECT Journal article
Jiang, Han, Du, Yu, Lu, Zhonglin, Wang, Bingjie, Zhao, Yonghua, Wang, Ruibing, Zhang, Hong, Mok, Greta S.P.. Radiomics incorporating deep features for predicting Parkinson’s disease in 123I-Ioflupane SPECT[J]. EJNMMI Physics, 2024, 11(1), 60.
Authors:  Jiang, Han;  Du, Yu;  Lu, Zhonglin;  Wang, Bingjie;  Zhao, Yonghua; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/3.7 | Submit date:2024/08/05
123i-ioflupane  Deep Feature  Deep Learning  Parkinson’s Disease  Radiomics  Spect  
Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation Journal article
Guo, Baojian, Zheng, Chengyou, Cao, Jie, Qiu, Xiaoling, Luo, Fangcheng, Li, Haitao, Lee, Simon Mingyuan, Yang, Xifei, Zhang, Gaoxiao, Sun, Yewei, Zhang, Zaijun, Wang, Yuqiang. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin–Proteasome System Activation[J]. NeuroMolecular Medicine, 2024, 26(1), 9.
Authors:  Guo, Baojian;  Zheng, Chengyou;  Cao, Jie;  Qiu, Xiaoling;  Luo, Fangcheng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.3/3.6 | Submit date:2024/05/16
Nuclear Factor Erythroid-2-related Factor 2  Parkinson’s Disease  Peroxisome Proliferator-activated Receptor γ Co-activator 1α  Tetramethylpyrazine Nitrone  Ubiquitin–proteasome System  Α-synuclein  
J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice Journal article
Pan, Zhijian, Shao, Min, Zhao, Chen, Yang, Xuanjun, Li, Haitao, Cui, Guozhen, Liang, Xiaonan, Yu, Chao Wu, Ye, Qingqing, Gao, Cheng, Di, Lijun, Chern, Ji Wang, Zhou, Hefeng, Lee, Simon Ming Yuen. J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice[J]. European Journal of Pharmaceutical Sciences, 2024, 194, 106696.
Authors:  Pan, Zhijian;  Shao, Min;  Zhao, Chen;  Yang, Xuanjun;  Li, Haitao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.3/4.2 | Submit date:2024/04/02
J24335  Parkinson's Disease  6-ohda  Neurotoxicity  Mitochondria Dysfunction  Target Prediction